Stock overview
Bristol-Myers Squibb Co.
Explore the company, reported ownership, price history, and available source evidence.
Bristol Myers Squibb develops medicines for oncology, immunology, cardiovascular disease, and hematology.
- Last close
- $59.56
- · BMY
- Tracked holders
- 3 funds
- Latest available 13F per fund
BMY · USD
Price
Close · Nov 18, 2026
- Range low
- $56.67
- Range high
- $68.09
- Observations
- 68
- Session date
- Nov 18, 2026
Aug 14, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | +27% 26'Q3 | $70,867,368 | 0.14% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $64,508,371 | 0.08% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | Newly reported 26'Q3 | $1,135,680 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market